GBH Insights’ Daniel Ives now looks for 19% in upside potential for Netflix stock.
Jeffrey Wlodarczak now anticipates 25% upside potential for Netflix after delving into an in-depth country by country review.
Goldman Sachs’ Mark Delaney now angles for 8% upside potential for MU shares.
Up more than 30% already yesterday, shares of Clearside Biomedical Inc (NASDAQ:CLSD) notched another 19% gain in Tuesday’s trading session. Why the excitement?
Shares of Genocea Biosciences Inc (NASDAQ:GNCA) rose nearly 17% in after-hours trading Monday after analysts at Cantor started covering the stock, rating it …
BTIG’s Ryan Zimmerman now spotlights 18% in return potential for VCEL shares on back of an impressive fourth quarter performance.
Conatus Pharmaceuticals Inc (NASDAQ:CNAT) is a mover and shaker out on the Street today, with investors sparking the stock on an almost 17% …
In a very upbeat and promising report, analyst Austin Moldow of Canaccord explains why he is initiating coverage on shares of Helios and Matheson Analytics …
Deutsche Bank’s Bryan Keane sings the praises of SQ’s “massive market opportunity” ahead.
Roth Capital’s Darren Aftahi now angles for 14% in return potential for SHOP stock ahead of Thursday’s quarterly print.